Advanced Infertility: Male



 
Empiric Medical Therapy of Male Subfertility
When an infertile man presents for evaluation, but no specific abnormalities are found to account for this problem, then the patient has idiopathic infertility. It is predictable that patients would expect a medical therapy to improve sperm production or quality, given the number and varieties of treatment that are now available for various medical problems. In my experience, patients frequently request, and are surprised by, the paucity of effective nonspecific medical treatments for male infertility.
http://www.maleinfertility.org/new-therapy.html
Men’s Health and Fertility Lifestyle Information
Y Chromosome Infertility
Disease characteristics. Y chromosome infertility is characterized by azoospermia (absence of sperm), severe oligozoospermia (<1 x 106 sperm/mL semen), moderate oligozoospermia (1-5 x 106 sperm/mL semen), or mild oligozoospermia (5-20 x 106 sperm/mL semen). Males with Y chromosome infertility usually have no obvious symptoms, although physical examination may reveal small testes and/or cryptorchidism.
http://www.genetests.org/servlet/access?db=geneclinics&site=gt&id=8888892&key=WjVURBazPL4YF&gry=&fcn
Spermatogenic Failure, Nonobstructive, Y-Linked
Azoospermia, Nonobstructive, Y-Linked Oligozoospermia, Nonobstructive, Y-Linked Oligospermia, Nonobstructive, Y-Linked Spermatogenic Arrest, Y-Linked Azoospermia Factor Regions, Included AZF Regions, Included
http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=415000
Y Deletion and Infertility
Y chromosome Inside Infertility
Deletions in the Y chromosome can lead to infertility. Mark Jobling is turning to fertile men to find out why such deletions occur.
http://genome.wellcome.ac.uk/doc_wtd020834.html
Genetic Abnormalities and Testing Y chromosome (AZF) microdeletions
Center for Male Reproductive Medicine and Microsurgery
http://www.maleinfertility.org/new-noa.html#azf
Y chromosome (AZF ) microdeletions
The diagnosis of azoospermia is often associated with a genetic etiology. For men with congenital absence of the vas deferens, 60% will have a detectable cystic fibrosis gene mutation 10. The female partner should also be tested to see if she is a carrier. If both partners are carriers, the risk of having a child affected by crystic fibrosis is 50%. Up to 17% or more men with NOA will have detectable genetic abnormalities that will only become apparent with the rudimentary tests of Y-chromosome partial deletion analysis and karyotype testing.
http://www.maleinfertility.org/new-retrieval4.html#genetic
Klinefelter's Syndrome
Klinefelter Syndrome

Previous Page | Next Page

© Copyright 2026; All rights reserved.         Tomorrow a Child is a recognized and certified 501c3 charity organization.